Li J et al. [109] developed two third-generation CAR-NK cell products, Claudin-6 (CLDN6)-CAR1 NK-92MI cells and CLDN6-CAR2 NK-92MI cells, which target CLDN6—an antigen overexpressed in ovarian cancer. This evidence concerns the gene CLDN6 and ovarian cancer.